Cargando…

Indole-3-Acetic Acid Alters Intestinal Microbiota and Alleviates Ankylosing Spondylitis in Mice

Ankylosing spondylitis (AS) is a systemic, chronic, and inflammatory autoimmune disease associated with the disorder of intestinal microbiota. Unfortunately, effective therapies for AS are lacking. Recent evidence has indicated that indole-3-acetic acid (IAA), an important microbial tryptophan metab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Jun, Yang, Lianjun, You, Ke, Chen, Tao, Su, Zhihai, Cui, Zhifei, Wang, Min, Zhang, Weicong, Liu, Bin, Zhou, Kai, Lu, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854167/ https://www.ncbi.nlm.nih.gov/pubmed/35185872 http://dx.doi.org/10.3389/fimmu.2022.762580

Ejemplares similares

Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice
por: Yang, Lianjun, et al.
Publicado: (2019)

Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice
por: Liu, Bin, et al.
Publicado: (2019)

A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis
por: Yang, Lianjun, et al.
Publicado: (2016)

Alterations in the gut virome in patients with ankylosing spondylitis
por: Li, Chen, et al.
Publicado: (2023)

Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway
por: Berlinberg, Adam J., et al.
Publicado: (2021)

Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
por: Chen, Zena, et al.
Publicado: (2021)

Case report: Fecal microbiota transplantation in refractory ankylosing spondylitis
por: Wang, Lei, et al.
Publicado: (2023)

Perspectives on the Genetic Associations of Ankylosing Spondylitis
por: Wordsworth, B. Paul, et al.
Publicado: (2021)

Role of the microbiome and its metabolites in ankylosing spondylitis
por: Song, Zi-Yi, et al.
Publicado: (2022)

Joint together: The etiology and pathogenesis of ankylosing spondylitis
por: Xiong, Yuehan, et al.
Publicado: (2022)

Peptidomics analysis of plasma in patients with ankylosing spondylitis
por: Zhang, Guo-ning, et al.
Publicado: (2023)

Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders
por: Fiorillo, Maria Teresa, et al.
Publicado: (2019)

Editorial: Advances in Pathogenesis, Etiology, and Therapies for Ankylosing Spondylitis
por: Chen, Chih-Wei, et al.
Publicado: (2021)

Genetically predicted ankylosing spondylitis is causally associated with psoriasis
por: Tian, Di, et al.
Publicado: (2023)

Intestinal Microbial Metabolites in Ankylosing Spondylitis
por: Scalise, Giuseppe, et al.
Publicado: (2021)

Characteristics of the intestinal microbiome in ankylosing spondylitis
por: Cardoneanu, Anca, et al.
Publicado: (2021)

FOXO3a Alleviates the Inflammation and Oxidative Stress via Regulating TGF-β and HO-1 in Ankylosing Spondylitis
por: Xu, Shanshan, et al.
Publicado: (2022)

GM-CSF Primes Proinflammatory Monocyte Responses in Ankylosing Spondylitis
por: Shi, Hui, et al.
Publicado: (2020)

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis
por: McGonagle, Dennis, et al.
Publicado: (2021)

Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome
por: Yu, Chaojie, et al.
Publicado: (2021)

Emerging Roles of Long Non-Coding RNAs in Ankylosing Spondylitis
por: Sun, Ruifu, et al.
Publicado: (2022)

Novel regulatory role of non-coding RNAs in ankylosing spondylitis
por: Fang, Yanyan, et al.
Publicado: (2023)

Dual Role of Indoles Derived From Intestinal Microbiota on Human Health
por: Ye, Xuewei, et al.
Publicado: (2022)

RUNX3 and T-Bet in Immunopathogenesis of Ankylosing Spondylitis—Novel Targets for Therapy?
por: Vecellio, Matteo, et al.
Publicado: (2019)

From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery
por: Nancy, Zaarour, et al.
Publicado: (2021)

Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
por: Ou, Jiayong, et al.
Publicado: (2021)

IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
por: Baeten, Dominique, et al.
Publicado: (2021)

Platelet-to-Lymphocyte Ratio as an Independent Factor Was Associated With the Severity of Ankylosing Spondylitis
por: Liang, Tuo, et al.
Publicado: (2021)

Ankylosing spondylitis and glaucoma in European population: A Mendelian randomization study
por: Li, Shengjie, et al.
Publicado: (2023)

Serum DKK-1 level in ankylosing spondylitis: insights from meta-analysis and Mendelian randomization
por: Fang, Xi, et al.
Publicado: (2023)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Prefoldin 5 and Anti-prefoldin 5 Antibodies as Biomarkers for Uveitis in Ankylosing Spondylitis
por: Kwon, Oh Chan, et al.
Publicado: (2019)

The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science
por: Watad, Abdulla, et al.
Publicado: (2018)

A Comprehensive Assessment of Hip Damage in Ankylosing Spondylitis, Especially Early Features
por: Han, Qing, et al.
Publicado: (2021)

Osteoarticular Involvement-Associated Biomarkers and Pathways in Psoriasis: The Shared Pathway With Ankylosing Spondylitis
por: Zhang, Yu-Ping, et al.
Publicado: (2022)

Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis
por: Liu, Dong, et al.
Publicado: (2021)

Vesicular traffic-mediated cell-to-cell signaling at the immune synapse in Ankylosing Spondylitis
por: Tavasolian, Fataneh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6vv3k8stjkffqf2u3bd12djtko